Last 12 months
Inside the activity.
2 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 2 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2025 Filed Jan 21, 2025 21:32 UTC |
DAS SANJIVPresident
|
GrantClass A Ordinary Share | 22,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000023 · wk-form4_1737495132.xml · nonDerivative · entry 1 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,445 Read SEC document |
| January 02, 2025 Filed Jan 4, 2025 00:53 UTC |
Rosen TamiDirector · Chief Development Officer
|
SaleClass A Ordinary Share | 21,547 | $9.97 | $214,823.59 |
DisclosureSEC source: 0001883085-25-000017 · wk-form4_1735952009.xml · nonDerivative · entry 2 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,550 F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the quarterly vesting of a compensatory award. Read SEC document |
| January 02, 2025 Filed Jan 4, 2025 00:52 UTC |
Perros EvangelosChief Financial Officer
|
SaleClass A Ordinary Share | 21,305 | $9.97 | $212,410.85 |
DisclosureSEC source: 0001883085-25-000015 · wk-form4_1735951923.xml · nonDerivative · entry 3 Perros Evangelos · CIK 0002018687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,029 F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the quarterly vesting of a compensatory award. Read SEC document |
| January 02, 2025 Filed Jan 4, 2025 00:51 UTC |
DAS SANJIVPresident
|
SaleClass A Ordinary Share | 6,343 | $9.97 | $63,239.71 |
DisclosureSEC source: 0001883085-25-000013 · wk-form4_1735951864.xml · nonDerivative · entry 2 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,528 F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the quarterly vesting of a compensatory award. Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:53 UTC |
Rosen TamiDirector · Chief Development Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 56,916 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000017 · wk-form4_1735952009.xml · derivative · entry 3 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,933 Underlying: Class A Ordinary Share · 56,916 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/3rd of the total 170,765 RSUs initially subject to this award vested on October 1, 2024, 1/3rd vested on January 1, 2025 and the remaining RSUs shall vest over the following two quarters in two equal installments. F2 · derivative.expiration_date: 1/3rd of the total 170,765 RSUs initially subject to this award vested on October 1, 2024, 1/3rd vested on January 1, 2025 and the remaining RSUs shall vest over the following two quarters in two equal installments. Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:53 UTC |
Rosen TamiDirector · Chief Development Officer
|
GrantClass A Ordinary Share | 56,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000017 · wk-form4_1735952009.xml · nonDerivative · entry 1 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,097 Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:52 UTC |
Perros EvangelosChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 45,546 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000015 · wk-form4_1735951923.xml · derivative · entry 5 Perros Evangelos · CIK 0002018687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,132 Underlying: Class A Ordinary Share · 45,546 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/6th of the total 273,224 restricted stock units subject to this award vested each on August 1, 2024 and January 1, 2025, and the remaining 2/3rd of the grant shall vest over the following 24 months in equal quarterly installments on April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026, April 1, 2026, July 1, 2026, October 1, 2026 and January 1, 2027. F3 · derivative.expiration_date: 1/6th of the total 273,224 restricted stock units subject to this award vested each on August 1, 2024 and January 1, 2025, and the remaining 2/3rd of the grant shall vest over the following 24 months in equal quarterly installments on April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026, April 1, 2026, July 1, 2026, October 1, 2026 and January 1, 2027. Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:52 UTC |
Perros EvangelosChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,166 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000015 · wk-form4_1735951923.xml · derivative · entry 4 Perros Evangelos · CIK 0002018687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Share · 4,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4th of the total 33,333 restricted stock units initially subject to this award vested on April 1, 2023, 1/4th of the total units initially subject to this award vested on January 1, 2024 and the reminder of the award vests in 4 equal installments every three months for the 12 months thereafter. F2 · derivative.expiration_date: 1/4th of the total 33,333 restricted stock units initially subject to this award vested on April 1, 2023, 1/4th of the total units initially subject to this award vested on January 1, 2024 and the reminder of the award vests in 4 equal installments every three months for the 12 months thereafter. Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:52 UTC |
Perros EvangelosChief Financial Officer
|
GrantClass A Ordinary Share | 45,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000015 · wk-form4_1735951923.xml · nonDerivative · entry 2 Perros Evangelos · CIK 0002018687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,334 Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:52 UTC |
Perros EvangelosChief Financial Officer
|
GrantClass A Ordinary Share | 4,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000015 · wk-form4_1735951923.xml · nonDerivative · entry 1 Perros Evangelos · CIK 0002018687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,788 Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:51 UTC |
DAS SANJIVPresident
|
Exercise / conversionRestricted Stock Unit · Derivative | 17,077 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000013 · wk-form4_1735951864.xml · derivative · entry 3 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,152 Underlying: Class A Ordinary Share · 17,077 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4th of the total 68,306 RSUs initially subject to this award vested on October 1, 2024, 1/4th vested on January 1, 2025 and the remaining RSUs shall vest over the following four quarters in four equal installments. F2 · derivative.expiration_date: 1/4th of the total 68,306 RSUs initially subject to this award vested on October 1, 2024, 1/4th vested on January 1, 2025 and the remaining RSUs shall vest over the following four quarters in four equal installments. Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:51 UTC |
DAS SANJIVPresident
|
GrantClass A Ordinary Share | 17,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000013 · wk-form4_1735951864.xml · nonDerivative · entry 1 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,871 Read SEC document |
| December 22, 2024 Filed Jan 3, 2025 01:04 UTC |
DAVIS ALISONDirector
|
GrantClass A Ordinary Share | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000011 · wk-form4_1735866292.xml · nonDerivative · entry 1 DAVIS ALISON · CIK 0001203539 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,750 F1 · security: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's Class A Ordinary Share. Represents an award of restricted stock units that vest pro rata on April 1, July 1 and October 1 of 2025. Read SEC document |
| December 22, 2024 Filed Jan 3, 2025 01:01 UTC |
Zeevi AviDirector
|
GrantClass A Ordinary Share | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000007 · wk-form4_1735866111.xml · nonDerivative · entry 1 Zeevi Avi · CIK 0001868879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,312 F1 · shares: At the time of this filing, it consists of 18,750 restricted stock units ("RSUs") and 6,250 Class A Ordinary Shares. Each RSU represents a contingent right to receive one share of the Company's Class A Ordinary Share. The grant vested 25% on January 1, and the remainder vests pro rata in 3 equal quarterly installments on each of April 1, July 1 and October 1 of 2025. The transactions reported herein are being reported late due to an inadvertent administrative delay and not any error of the Reporting Person. Read SEC document |
| December 22, 2024 Filed Jan 3, 2025 00:55 UTC |
Petrozzo DanDirector
|
GrantClass A Ordinary Share | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000005 · wk-form4_1735865721.xml · nonDerivative · entry 1 Petrozzo Dan · CIK 0001970430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,762 F1 · shares: At the time of this filing, it consists of 18,750 restricted stock units ("RSUs") and 6,250 Class A Ordinary Shares. Each RSU represents a contingent right to receive one share of the Company's Class A Ordinary Share. The grant vested 25% on January 1, and the remainder vests pro rata in 3 equal quarterly installments on each of April 1, July 1 and October 1 of 2025. The transactions reported herein are being reported late due to an inadvertent administrative delay and not any error of the Reporting Person. Read SEC document |
| December 22, 2024 Filed Jan 3, 2025 00:53 UTC |
GOLUB HARVEYDirector
|
GrantClass A Ordinary Share | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000003 · wk-form4_1735865583.xml · nonDerivative · entry 1 GOLUB HARVEY · CIK 0001189771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,312 F1 · shares: At the time of this filing, it consists of 18,750 restricted stock units ("RSUs") and 6,250 Class A Ordinary Shares. Each RSU represents a contingent right to receive one share of the Company's Class A Ordinary Share. The grant vested 25% on January 1, and the remainder vests pro rata in 3 equal quarterly installments on each of April 1, July 1 and October 1 of 2025. The transactions reported herein are being reported late due to an inadvertent administrative delay and not any error of the Reporting Person. Read SEC document |
| December 22, 2024 Filed Jan 14, 2025 21:53 UTC |
Mehta AsheetDirector
|
GrantClass A Ordinary Share | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000021 · wk-form4_1736891624.xml · nonDerivative · entry 1 Mehta Asheet · CIK 0002051877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,750 F1 · security: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's Class A Ordinary Share. Represents an award of restricted stock units that vest pro rata on April 1, July 1 and October 1 of 2025. Read SEC document |
| December 22, 2024 Filed Feb 4, 2025 21:10 UTC Amendment |
DAVIS ALISONDirector
|
GrantClass A Ordinary Share | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-25-000028 · wk-form4a_1738703426.xml · nonDerivative · entry 1 DAVIS ALISON · CIK 0001203539 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Fifth Era LLC Disclosed balance after: 18,750 F1 · balance_after: Represents an award of restricted stock units that vest pro rata on April 1, July 1 and October first following the award commencement date. F2 · ownership.direct: This Form 4 amendment is being filed to correct the nature of the ownership of the securities previously reported as directly owned by the Reporting Person. Such securities are indirectly held by a limited liability company owned 100% by the Reporting Person and her spouse. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 22:01 UTC |
Torraco NicoleDirector
|
SaleClass A Ordinary Share | 2,371 | $8.92 | $21,160.70 |
DisclosureSEC source: 0001883085-24-000192 · wk-form4_1731967274.xml · nonDerivative · entry 2 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,487 F1 · kind: Shares were sold in large part to cover taxes incurred upon the vesting of restricted stock units pursuant to a Rule 10b5-1 plan dated March 21, 2024. F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $9.33 to $8.68 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 22:01 UTC |
Torraco NicoleDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,743 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000192 · wk-form4_1731967274.xml · derivative · entry 3 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Share · 4,743 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4th of the total 18,972 restricted stock units initially subject to this award vested on February 14, 2024, and the remaining total units initially subject to this award vests quarterly in 3 equal installments. F3 · derivative.expiration_date: 1/4th of the total 18,972 restricted stock units initially subject to this award vested on February 14, 2024, and the remaining total units initially subject to this award vests quarterly in 3 equal installments. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 22:01 UTC |
Torraco NicoleDirector
|
GrantClass A Ordinary Share | 4,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000192 · wk-form4_1731967274.xml · nonDerivative · entry 1 Torraco Nicole · CIK 0002018133 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,858 Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 21:43 UTC |
Yulzari YahavDirector · Chief Business Officer
|
SaleClass A Ordinary Share | 150,000 | $15.50 | $2,324,790.00 |
DisclosureSEC source: 0001883085-24-000189 · wk-form4_1731447820.xml · nonDerivative · entry 1 Yulzari Yahav · CIK 0001935202 · Director · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 161,637 F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information. F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $16.0450 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 21:42 UTC |
Pardo AvitalDirector · Chief Technology Officer
|
SaleClass A Ordinary Share | 150,000 | $15.50 | $2,325,165.00 |
DisclosureSEC source: 0001883085-24-000187 · wk-form4_1731447742.xml · nonDerivative · entry 1 Pardo Avital · CIK 0001935207 · Director · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,125 F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information. F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $16.05 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 21:41 UTC |
Rosen TamiDirector · Chief Development Officer
|
SaleClass A Ordinary Share | 27,676 | $15.15 | $419,224.98 |
DisclosureSEC source: 0001883085-24-000185 · wk-form4_1731447670.xml · nonDerivative · entry 1 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,181 F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information. F2 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.37 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 21:04 UTC |
Rosen TamiDirector · Chief Development Officer
|
SaleClass A Ordinary Share | 7,659 | $12.00 | $91,908.00 |
DisclosureSEC source: 0001883085-24-000177 · wk-form4_1731013446.xml · nonDerivative · entry 1 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,857 F1 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 22:01 UTC |
Rosen TamiDirector · Chief Development Officer
|
SaleClass A Ordinary Share | 7,966 | $11.57 | $92,166.62 |
DisclosureSEC source: 0001883085-24-000175 · wk-form4_1730757668.xml · nonDerivative · entry 2 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,086 F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 22:01 UTC |
Rosen TamiDirector · Chief Development Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,625 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000175 · wk-form4_1730757668.xml · derivative · entry 4 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,625 Underlying: Class A Ordinary Share · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/4th of the total 125,000 restricted stock units initially subject to this award vested on each of October 31, 2023 and January 31, 2024, and the remaining vests quarterly, in four equal installments. F4 · derivative.expiration_date: 1/4th of the total 125,000 restricted stock units initially subject to this award vested on each of October 31, 2023 and January 31, 2024, and the remaining vests quarterly, in four equal installments. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 22:01 UTC |
Rosen TamiDirector · Chief Development Officer
|
SaleClass A Ordinary Share | 17,570 | $12.06 | $211,913.53 |
DisclosureSEC source: 0001883085-24-000175 · wk-form4_1730757668.xml · nonDerivative · entry 3 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,516 F2 · kind: This sale was effected pursuant to a 10b5-1 plan, as noted on the form specific filing information. F3 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.21 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 22:01 UTC |
Rosen TamiDirector · Chief Development Officer
|
Exercise / conversionClass A Ordinary Share | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000175 · wk-form4_1730757668.xml · nonDerivative · entry 1 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2024 Filed Oct 17, 2024 23:44 UTC |
DAS SANJIVPresident
|
SaleClass A Ordinary Share | 10,683 | $11.77 | $125,738.91 |
DisclosureSEC source: 0001883085-24-000169 · wk-form4_1729208662.xml · nonDerivative · entry 2 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,794 F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award. Read SEC document |
| October 16, 2024 Filed Oct 17, 2024 23:44 UTC |
DAS SANJIVPresident
|
GrantRestricted Stock Unit · Derivative | 22,917 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000169 · wk-form4_1729208662.xml · derivative · entry 4 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,588 Underlying: Class A Ordinary Share · 22,917 shares Expires not disclosed F3 · derivative.exercise_date: 1/4th of the total 183,333 RSUs initially subject to this award vested on April 16, 2024, and the remaining RSUs shall vest thereafter in 6 equal quarterly installments beginning on July 16, 2024. F3 · derivative.expiration_date: 1/4th of the total 183,333 RSUs initially subject to this award vested on April 16, 2024, and the remaining RSUs shall vest thereafter in 6 equal quarterly installments beginning on July 16, 2024. Read SEC document |
| October 16, 2024 Filed Oct 17, 2024 23:44 UTC |
DAS SANJIVPresident
|
GrantStock Options (Right to Buy) · Derivative | 700,000 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000169 · wk-form4_1729208662.xml · derivative · entry 3 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 Underlying: Class A Ordinary Share · 700,000 shares Expires 2034-10-15 F2 · derivative.exercise_date: 1/4th of the total 700,000 options will vest one year after the commencement date on October 16, 2025, and the remaining shall vest over the following 3 years in annual installments on the vesting anniversary. F2 · derivative.expiration_date: 1/4th of the total 700,000 options will vest one year after the commencement date on October 16, 2025, and the remaining shall vest over the following 3 years in annual installments on the vesting anniversary. Read SEC document |
| October 16, 2024 Filed Oct 17, 2024 23:44 UTC |
DAS SANJIVPresident
|
GrantClass A Ordinary Share | 22,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000169 · wk-form4_1729208662.xml · nonDerivative · entry 1 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,477 Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:20 UTC |
Kim Nam WooSee Remarks
|
GrantRestricted Stock Unit · Derivative | 326 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000165 · wk-form4_1729023611.xml · derivative · entry 3 Kim Nam Woo · CIK 0002039223 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,608 Underlying: Class A Ordinary Share · 326 shares Expires not disclosed F2 · derivative.exercise_date: 1/4th of the total 5,216 restricted stock units vested on April 11, 2023, and the remaining shall vest over the following three years in 12 equal quarterly installments. F2 · derivative.expiration_date: 1/4th of the total 5,216 restricted stock units vested on April 11, 2023, and the remaining shall vest over the following three years in 12 equal quarterly installments. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:20 UTC |
Kim Nam WooSee Remarks
|
SaleClass A Ordinary Share | 133 | $10.83 | $1,440.39 |
DisclosureSEC source: 0001883085-24-000165 · wk-form4_1729023611.xml · nonDerivative · entry 2 Kim Nam Woo · CIK 0002039223 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,180 F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:20 UTC |
Kim Nam WooSee Remarks
|
GrantClass A Ordinary Share | 326 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000165 · wk-form4_1729023611.xml · nonDerivative · entry 1 Kim Nam Woo · CIK 0002039223 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,313 Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:05 UTC |
Kim Nam WooSee Remarks
|
SaleClass A Ordinary Share | 171 | $9.90 | $1,692.90 |
DisclosureSEC source: 0001883085-24-000159 · wk-form4_1727985938.xml · nonDerivative · entry 2 Kim Nam Woo · CIK 0002039223 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,987 F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:05 UTC |
Perros EvangelosChief Financial Officer
|
SaleClass A Ordinary Share | 2,336 | $9.90 | $23,126.40 |
DisclosureSEC source: 0001883085-24-000158 · wk-form4_1727985898.xml · nonDerivative · entry 2 Perros Evangelos · CIK 0002018687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,622 F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:04 UTC |
Rosen TamiDirector · Chief Development Officer
|
SaleClass A Ordinary Share | 29,240 | $9.90 | $289,476.00 |
DisclosureSEC source: 0001883085-24-000157 · wk-form4_1727985869.xml · nonDerivative · entry 2 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,427 F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:03 UTC |
DAS SANJIVPresident
|
SaleClass A Ordinary Share | 8,022 | $9.90 | $79,417.80 |
DisclosureSEC source: 0001883085-24-000155 · wk-form4_1727985790.xml · nonDerivative · entry 2 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,560 F1 · kind: Sale of securities was necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC |
Kim Nam WooSee Remarks
|
GrantRestricted Stock Unit · Derivative | 417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000159 · wk-form4_1727985938.xml · derivative · entry 3 Kim Nam Woo · CIK 0002039223 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,083 Underlying: Class A Ordinary Share · 417 shares Expires not disclosed F2 · derivative.exercise_date: 1/4 of the total 3,333 initially subjected to this award vested on April 1, 2023, 1/4 vested on January 1, 2024, and the remaining RSUs shall vest thereafter in 4 equal quarterly installments beginning on April 1, 2024, and thereafter. F2 · derivative.expiration_date: 1/4 of the total 3,333 initially subjected to this award vested on April 1, 2023, 1/4 vested on January 1, 2024, and the remaining RSUs shall vest thereafter in 4 equal quarterly installments beginning on April 1, 2024, and thereafter. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC |
Kim Nam WooSee Remarks
|
GrantClass A Ordinary Share | 417 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000159 · wk-form4_1727985938.xml · nonDerivative · entry 1 Kim Nam Woo · CIK 0002039223 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,158 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC |
Perros EvangelosChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 4,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000158 · wk-form4_1727985898.xml · derivative · entry 3 Perros Evangelos · CIK 0002018687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,166 Underlying: Class A Ordinary Share · 4,167 shares Expires not disclosed F2 · derivative.exercise_date: 1/4th of the total 33,333 restricted stock units initially subject to this award vested on April 1, 2023, 1/4th of the total units initially subject to this award vested on January 1, 2024 and the reminder of the award vests in 4 equal installments every three months for the 12 months thereafter. F2 · derivative.expiration_date: 1/4th of the total 33,333 restricted stock units initially subject to this award vested on April 1, 2023, 1/4th of the total units initially subject to this award vested on January 1, 2024 and the reminder of the award vests in 4 equal installments every three months for the 12 months thereafter. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC |
Perros EvangelosChief Financial Officer
|
GrantClass A Ordinary Share | 4,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000158 · wk-form4_1727985898.xml · nonDerivative · entry 1 Perros Evangelos · CIK 0002018687 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,958 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:04 UTC |
Rosen TamiDirector · Chief Development Officer
|
GrantRestricted Stock Unit · Derivative | 56,916 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000157 · wk-form4_1727985869.xml · derivative · entry 3 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,849 Underlying: Class A Ordinary Share · 56,916 shares Expires not disclosed F2 · derivative.exercise_date: 1/3rd of the total 170,765 RSUs initially subject to this award vested on October 1, 2024, 1/3rd will vest on January 1, 2025 and the remaining RSUs shall vest over the following two quarters in two equal installments. F2 · derivative.expiration_date: 1/3rd of the total 170,765 RSUs initially subject to this award vested on October 1, 2024, 1/3rd will vest on January 1, 2025 and the remaining RSUs shall vest over the following two quarters in two equal installments. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:04 UTC |
Rosen TamiDirector · Chief Development Officer
|
GrantClass A Ordinary Share | 56,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000157 · wk-form4_1727985869.xml · nonDerivative · entry 1 Rosen Tami · CIK 0001970282 · Director · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,667 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:03 UTC |
DAS SANJIVPresident
|
GrantRestricted Stock Unit · Derivative | 17,077 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000155 · wk-form4_1727985790.xml · derivative · entry 3 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,229 Underlying: Class A Ordinary Share · 17,077 shares Expires not disclosed F2 · derivative.exercise_date: 1/4th of the total 68,306 RSUs initially subject to this award vested on October 1, 2024, 1/4th will vest on January 1, 2025 and the remaining RSUs shall vest over the following four quarters in four equal installments. F2 · derivative.expiration_date: 1/4th of the total 68,306 RSUs initially subject to this award vested on October 1, 2024, 1/4th will vest on January 1, 2025 and the remaining RSUs shall vest over the following four quarters in four equal installments. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:03 UTC |
DAS SANJIVPresident
|
GrantClass A Ordinary Share | 17,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000155 · wk-form4_1727985790.xml · nonDerivative · entry 1 DAS SANJIV · CIK 0001654849 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,582 Read SEC document |
| September 30, 2024 Filed Oct 9, 2024 21:42 UTC |
Yulzari YahavDirector · Chief Business Officer
|
PurchaseClass A Ordinary Share | 23,600 | $10.52 | $248,170.52 |
DisclosureSEC source: 0001883085-24-000163 · wk-form4_1728510160.xml · nonDerivative · entry 1 Yulzari Yahav · CIK 0001935202 · Director · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 311,637 F1 · price: Represents the weighted average purchase price of a series of open market transactions with purchase prices ranging between $10.50 and $11.49. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:07 UTC |
Zeevi AviDirector
|
GrantRestricted Stock Unit · Derivative | 2,828 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001883085-24-000132 · wk-form4_1726603613.xml · derivative · entry 4 Zeevi Avi · CIK 0001868879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Ordinary Share · 2,828 shares Expires not disclosed F1 · derivative.exercise_date: 1/4th of the total 11,312 restricted stock units initially subject to this award vested on December 13, 2023, and 1/4th of the total units initially subject to this award vested every three months thereafter. F1 · derivative.expiration_date: 1/4th of the total 11,312 restricted stock units initially subject to this award vested on December 13, 2023, and 1/4th of the total units initially subject to this award vested every three months thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.